Project Grant R44MH144704
Award Date 9/25/25
Completion Date 8/31/27
Dollars Obligated $1.8M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Woodway, WA 98020, USA
Similar Awards
- The National Institute of Mental Health (NIMH) awarded a $314,113 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Physical Sciences Inc. (PSI) of Andover, MA. The grant will fund the development and demonstration of a high-speed, multicolor confocal fluorescence imager to simultaneously capture multi-wavelength signals and display them as separated or merged multicolor images and 3-D stacks. This technology innovation will enable mapping of complex neuronal network...
- The National Institute of Mental Health (NIMH) awarded a $1,596,935 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Petcoil, Inc., a for-profit company based in Sunnyvale, California. The grant, awarded on March 11, 2025, with a planned completion date of February 29, 2028, supports the commercialization of a portable, brain-dedicated Positron Emission Tomography (PET) insert system that can be integrated with existing Magnetic Resonance Imaging (MRI) machines....
- The National Institute of Mental Health (NIMH) awarded a $925,411 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Capesym Inc. (doing business as Cape Simulations), a small for-profit manufacturer in Natick, MA. The grant, awarded on September 1, 2025, will support the development and validation of high-performance, low-cost direct-conversion X-ray imaging technology based on perovskite sensors for medical imaging applications. The research objectives include...
- This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is supporting research to develop a highly optimized two-photon (2P) multiplexing system for enabling high-fidelity, large-scale voltage imaging of neuronal activity in vivo. The $768,000 grant, awarded on September 20, 2025, aims to address the technical challenges of current voltage imaging techniques, which have been limited to small neuron...
- This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) is providing $449,390 to develop a precision functional neuroimaging platform to enable the collection of highly-sampled brain data by patients at home. The award was granted to Walnot, Inc. (UEI: N9QEPY3AHYM8) and runs from September 1, 2025 to August 31, 2027. The platform integrates a low-cost, wireless, wearable functional near infrared...
- The National Institute of Mental Health (NIMH) awarded a $505,311 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Intelligent Imaging Innovations, Inc. (3i), a for-profit manufacturer of advanced microscopy equipment and software based in Denver, Colorado. The two-year grant, awarded on January 1, 2025, seeks to establish the feasibility of combining recent advances in optical techniques to produce a commercial instrument that enables large-scale, all-optical...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $305,000 Project Grant (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) to Odmr Technologies, Inc. to develop a miniature diamond quantum sensor for magnetoencephalography (MEG). The key objectives are to: 1) Build a miniature flux-concentrator diamond sensor with infrared absorption detection, and 2) Demonstrate a sensitivity of ~10 femtotesla for 1 second...
- The National Institute of Mental Health (NIMH) awarded a $380,375 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Ceretype Neuromedicine Inc. to develop an advanced functional MRI (fMRI) software platform for use in clinical trials and therapeutic applications in neuropsychiatry. The project aims to create a standardized, automated fMRI solution that improves the sensitivity, reliability, and efficiency of using fMRI to evaluate the neurobiological mechanisms and...
- The National Institute of Mental Health (NIMH) awarded a $1,244,076 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Spatial Genomics, Inc. located in Pasadena, California. The purpose of this 2-year award, with a period of performance from June 1, 2025 to May 31, 2027, is to develop next-generation reagents and assays to scale up the multiplexity of the company's Gene Positioning System (GenEPS) platform. This spatial genomics technology, based on sequential...
- This Project Grant award of $517,546, awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to optimize, benchmark, and validate a novel multimodal microelectrode array (MEA) probe that integrates fast-scan cyclic voltammetry (FSCV) for sub-second neuromodulator sensing with parallel electrical recording. The research team, led by investigators from Dartmouth College, aims to develop this integrated MEA platform...